MARKET

NBI

NBI

NASDAQ Biotechnology Index
IDXNASDAQ
4,246.20
+4.88
+0.12%
Closed 14:15 11/25 EST
OPEN
4,224.05
PREV CLOSE
4,241.32
HIGH
4,253.10
LOW
4,216.94
52 WEEK HIGH
4,916.03
52 WEEK LOW
3,323.42
VOLUME
0
% RANGE
--
1D
5D
1M
3M
1Y
5Y
If this stock market is shaping up like 2008, here’s where we could be headed next, says strategist
Comparisons between 2022 and 2008 are making the rounds. Here's one look at what that might mean in the months ahead.
marketwatch.com · 07/11 11:08
Achilles Therapeutics Added To NASDAQ Biotechnology Index As Of Dec. 20, 2021
Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company has been added to the NASDAQ Biotech Index
Benzinga · 12/20/2021 13:13
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Mon
Benzinga · 12/17/2021 16:15
Teknova To Join Nasdaq Biotechnology Index Effective Dec. 20, 2021
 Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and
Benzinga · 12/15/2021 23:06
Sera Prognostics Added To Nasdaq Biotechnology Index As Of Dec. 20, 2021
 Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today
Benzinga · 12/15/2021 13:33
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · 12/15/2021 13:01
ALX Oncology Added to the NASDAQ Biotechnology Index
ALX Oncology Holdings Inc., (“ALX Oncology”) (NASDAQ:ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that it has been selected for
Benzinga · 12/17/2020 12:03
Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the
Benzinga · 12/16/2020 12:00
More